Register Now

When

Sat, Sep. 17, 2022
8 am - 3 pm
(GMT-05:00) America/Chicago

Where

James A. Baker III Hall, Rice University

The Texas Collaborative Center for Hepatocellular Cancer (TeCH) at Baylor College of Medicine hosted its third annual symposium on September 17, 2022, under the leadership of Dr. Hashem El-Serag. The event featured a keynote address by Dr. John Ward, director of the Task Force for Global Health’s Coalition for Global Hepatitis Elimination, who discussed how to move from science to policy to eliminate hepatocellular carcinoma (HCC), the most common type of primary liver cancer. 

This year's symposium combined presentations on current HCC research with a multi-stakeholder conference that brought together elected officials and decision-makers, community groups and industry representatives. Veterans Affairs leadership and professional societies also convened to discuss HCC in Texas and how they might guide strategies to improve HCC prevention, screening, diagnosis and treatment.

With one of the highest rates of end-stage liver disease and liver cancer in the country, Texas is uniquely impacted by this issue. Stakeholders across the care continuum considered how best to bridge the gaps in prevention and treatment of HCC in Texas, with a focus on driving advocacy efforts for policies aimed at statewide elimination of liver cancer/HCC and hepatitis. 

This event was co-sponsored by the Baker Institute Center for Health and Biosciences and the Texas Collaborative Center for Hepatocellular Cancer (TeCH) at Baylor College of Medicine (funded by the Cancer Prevention and Research Institute of Texas).

Follow @BakerCHB on Twitter, and join the conversation online with #BakerHealth.

 

 

Registration

Registration has closed.

Events and webinars are powered by the contributions of our donors and members. Please consider supporting our work by making a gift or joining a membership group. Learn more here or text BAKER to 243725 to give today.

Agenda

8:00 am

Session I: Overview of the Liver Cancer Epidemic in Texas

Moderator: Amit Singal, M.D., Medical Director, Liver Tumor Program and Clinical Chief of Hepatology, UT Southwestern Medical Center

Welcome and Overview
Hashem B. El-Serag, M.D., MPH
Chair and Professor, Department of Medicine, Baylor College of Medicine
Liver Cirrhosis and Cancer 101: Disease Burden, Risk Factors and Disparities
Aaron P. Thrift, Ph.D.
Associate Professor, Department of Medicine, Baylor College of Medicine

8:40 am

Session II: Advances and Gaps in Risk Assessment and Prevention

Moderator: Jane Montealegre, Ph.D., Deputy Director, Office of Outreach and Health Disparities, Dan L. Duncan Comprehensive Cancer Center; Assistant Professor, Department of Pediatrics, Baylor College of Medicine

Current State of Prevention in Liver Cancer and Gaps in Prevention
Sumeet K. Asrani, M.D., MSc
Transplant Hepatologist, Baylor University Medical Center, Baylor Scott & White Health
Addressing Gaps 1: Risk Assessment as a Tool in Prevention of Liver Cancer
Brett Forune, M.D., MSc
Medical Director of Liver Transplant, Montefiore Health System
Addressing Gaps 2: Prevention of Liver Cancer in the Community and Primary Care Settings
Barbara Turner, M.D., MSEd, MA, MACP
Clinical Professor of Medicine, Gehr Family Center for Health Systems Science and Innovation, University of Southern California

9:40 am

Discussion

10:00 am

Coffee Break 

10:20 am

Session III: Advances and Gaps in Detection and Treatment

Moderator: Sumeet Asrani, M.D., MSc, Transplant Hepatologist, Baylor University Medical Center, Baylor Scott & White Health

Current State of the Science in Detection and Diagnosis of Liver Cancer
Amit Singal, M.D.
Medical Director, Liver Tumor Program and Chief of Hepatology, UT Southwestern Medical Center
Current Treatment for Liver Cancer
Ahmed O. Kaseb, M.D.
Professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Addressing Gaps 3: Detection, Diagnosis and Treatment of Liver Cancer at the Community Level
Nicole Rich, M.D., MScS
Assistant Professor of Internal Medicine, UT Southwestern Medical Center
11:20 am

Discussion

11:40 am

Keynote Address and Lunch

John Ward, M.D.
Director, Coalition for Global Hepatitis Elimination, Task Force for Global Health

12:20 pm

Session IV: Implementing Change

Moderator: Hashem El-Serag, M.D., MPH, Chair and Professor, Department of Medicine, Baylor College of Medicine

Toward Policy Change — Payer Perspective
Salil Deshpande, M.D., MBA
Chief Medical Officer, UnitedHealthcare Community Plan
Putting It All Together: What Does an Ideal Road Map Look Like
Fasiha Kanwal, M.D., MSHS
Professor and Section Chief, Department of Medicine, Baylor College of Medicine
1:00 pm

Multi-stakeholder Meeting

2:30 pm

Adjourn

Register Now
Register Now

When

Sat, Sep. 17, 2022
8 am - 3 pm
(GMT-05:00) America/Chicago

Where

James A. Baker III Hall, Rice University